The human mRNA 5′-capping enzyme cDNA was identified. Three highly related cDNAs, HCE1 (human mRNA capping enzyme 1), HCE1A and HCE1B, were isolated from a HeLa cDNA library. The HCE1 cDNA has the longest ORF, which can encode a 69 kDa protein.
INTRODUCTION
Almost all eukaryotic mRNAs are capped at their 5′-termini (1) . Such modification by capping has been shown to be crucial for the stabilization (2-4), processing (5-10), nuclear export (11) , and translation of mRNA (see refs 12,13 for reviews). Capping occurs at an early stage of transcription and requires at least three enzymatic activities, mRNA 5′-triphosphatase (termed TPase in this study), mRNA 5′-guanylyltransferase (termed GTase in this study), and cap methyltransferase (termed MTase in this study) (see refs 14,15 for reviews). GTase and TPase activities are associated in one enzyme called mRNA 5′-capping enzyme (termed capping enzyme in this study), but MTase activity is dissociated from these two activities (16, 17) .
In Saccharomyces cerevisiae the capping enzyme consists of two subunits, α and β. The 52 kDa α-subunit is authentic for GTase activity, and the 80 kDa β-subunit is responsible for TPase activity (18) . Three yeast GTase genes have been cloned from S.cerevisiae (19) , Schizosaccharomyces pombe (20) and Candida albicans (21) , and their products were found to possess only GTase activity, demonstrating that subunit structure is a characteristic of yeast capping enzymes. Recently CET1 was identified as the gene for the S.cerevisiae TPase (β subunit of capping enzyme) (22) .
In addition to yeast GTases, chlorella virus PBCV-1 GTase was identified as a 38 kDa protein (23) . This is the smallest protein reported as a GTase to date, and no TPase activity is associated with this protein. The finding of PBCV-1 GTase implies that the chlorella virus capping enzyme has a subunit structure similar to those of the yeast capping enzymes, and the crystal structure of chlorella virus PBCV GTase is solved (24) . The enzyme consists of two domains with a cleft between them. The structure of GTase resembles that of T7 DNA ligase; T7 DNA ligase also comprises two domains which produce a cleft between them (25) . The cleft observed in GTase, however, is much deeper and narrower than that of DNA ligase, which may account for the substrate specificity of capping enzyme for single strand RNA molecules. After binding to manganese ions, the enzyme undergoes a big conformational change from open state to closed state, which may facilitate the hydrolysis of β and γ phosphoryl groups of bound GTP to form a stable enzyme-GMP complex (24) .
On the other hand, mammalian capping enzyme was purified as a 69 kDa single polypeptide having both TPase and GTase activities (26) . Recently, a cDNA for the CEL1 gene was isolated from Caenorhabiditis elegans (27) . In the putative protein Cel1p, the C-terminal part is highly related to yeast and viral GTases, while the N-terminal region contains an amino acid sequence motif that is characteristic of the active site of protein tyrosine phosphatase families. Despite the sequence similarity of Cel1p to the protein tyrosine phosphatases, a recombinant Cel1p does not recognize phosphotyrosine, but instead catalyzes the hydrolysis of a γ-phosphoryl group at the 5′-termini of RNAs, suggesting *To whom correspondence should be addressed. Tel: +81 467 47 2213; Fax: +81 467 46 5320; Email: hisafumi.okabe@roche.com Downloaded from https://academic.oup.com/nar/article-abstract/26/7/1700/1041144 by guest on 18 April 2019 that protein tyrosine phosphatases and TPase share a similar catalytic mechanism (27) . Although GTase activity of Cel1p remains to be established, all of these facts support the idea that Cel1p is a capping enzyme of C.elegans.
To gain more insight into the characteristics of a higher eukaryotic capping enzyme, we have isolated a cDNA for the human capping enzyme. Three highly related cDNAs were identified from a HeLa cDNA library. Comparison of the amino acid sequences of the expected products of these cDNAs revealed that two of them have deletions in the C-terminal half of the longest cDNA product, and that only the longest cDNA product has GTase activity, whereas all three cDNA products are active as TPase. Moreover, the human capping enzyme cDNAs defective in GTase did not functionally complement the S.cerevisiae CET1. Thus, it seems that the human capping enzyme mRNA is alternatively spliced producing GTase-deficient enzymes, and that the human and yeast TPases are functionally diverged.
MATERIALS AND METHODS

Screening of a HeLa cDNA library
The KXDG motif characteristic of proteins forming a stable enzyme-nucleotide monophosphate complex was used to search human genome and cDNA databases, and a short cDNA sequence in the Incyte Lifeseqt database (http://www.incyte.com/ ) was found to harbor a sequence of ADG. Using the nucleotide sequence of this clone, a 0.5 kb DNA fragment was amplified from a HeLa cDNA library by PCR, and it was used as a probe for cloning a full length cDNA. Primers used to amplify the probe DNA were, 5′-CCCGGGAATTCAGACTGGGAGGCTTCCATT-3′ and 5′-CCCGGGAATTCGGCTCGAGAGCAGATGGTA-3′. Hybridization and washing of the filters were carried out under stringent conditions [20 mM sodium phosphate (pH 7.2), 5× SSC (1× SSC contains 150 mM NaCl and 15 mM sodium citrate), 5× Denhardt's solution, 0.1% (w/v) SDS, 50% (v/v) formamide at 42_C for hybridization; 0.1× SSC and 0.1% SDS at 50_C for washing], and phages that were strongly hybridized with the probe DNA were collected. After a third screening, phages from the positive plaques were expanded, and the phage DNA was extracted (28) . Then cDNA insert was excised from the λgt10 vector by digesting the phage DNA with NotI and SalI, and cloned at the SmaI site of pUC19. Radiolabelling the probe DNA was performed by the random priming method using [α-32 P]dCTP (28) , and DNA sequencing was carried out as described elsewhere (28) . A HeLa cDNA library was purchased from Clontech (USA).
Expression and purification of the recombinant capping enzyme
For subcloning the human capping enzyme cDNAs, EcoRV sites were generated at both ends of ORFs using EcoRV linkers. The coding regions of the human capping enzyme cDNAs (HCE1, HCE1A and HCE1B) and the S.cerevisiae CEG1 gene were cloned at BamHI and SmaI sites of pGEX2T, respectively (29) , and the resulting plasmids were transfected into Escherichia coli JM109 to let them express recombinant yeast and human capping enzymes as a fusion with GST. Induction of expression of recombinant capping enzymes were carried out with IPTG as described (29) . At 4 h after the addition of IPTG, the bacterial cells were harvested, suspended in buffer A containing 20 mM Tris-HCl (pH 7.5), 0.5 mM EDTA, 50 mM NaCl, 10 mM β-mercaptoethanol, 10%(v/v) glycerol, 0.05% (v/v) NP-40 and 1 mM PMSF (phenylmethylsulfonyl fluoride), and lysed by sonication. Cell debris were removed by centrifugation at 15 000 g at 4_C for 30 min, and the supernatant was added to glutathione Sepharose CL-4B beads that were equilibrated with buffer A. After a gentle rotation at 4_C for 1 h, the beads were extensively washed with buffer A and subjected to western blotting or enzyme assays.
Assays for capping enzyme
An assay for enzyme-GMP complex formation was performed in a standard reaction mixture containing 20 mM Tris-HCl (pH 7.5), 3 mM MgCl 2 , 10 mM dithiothreitol, 0.4 mg/ml bovine serum albumin, 2 mg/ml inorganic pyrophosphatase, 20%(v/v) glycerol, 1 mM PMSF, 1 mM [α-32 P]GTP (specific activity 1 × 10 5 c.p.m./pmol), and ∼0.1 µg protein of the fusion proteins that bound to the glutathione Sepharose CL-4B beads at 30_C for 10 min (30) . After the reaction, the proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and the proteins that were covalently bound to GMP were visualized by autoradiography.
For a TPase assay, the glutathione Sepharose CL-4B beads in complex with ∼0.1 µg protein of the purified fusion proteins were washed three times with buffer B containing 50 mM Tris-HCl (pH 7.9) and 2 mM dithiothreitol and were then incubated with [γ-32 P]ATP-terminated RNA at 30_C for 30 min (26) . After removing the beads by a brief centrifugation, the reaction mixture was analysed by TLC using polyethyleneimine cellulose plates, and the spots were visualized by Fuji BAS 2000. The [γ-32 P]ATPterminated RNA was prepared as follows. Heat-denatured calf thymus DNA (50 µg) was incubated in a buffer containing 100 mM Tris-HCl (pH 7.9), 2 mM dithiothreitol, 5 mM Mg(OAc) 2 , 2 mM MnCl 2 , 1 mM [γ-32 P]ATP (1000-5000 c.p.m./ pmol), and 1 U E.coli RNA polymerase at 37_C for 90 min (26) . After extracting with phenol/chloroform, [γ-32 P]ATP-terminated RNA was precipitated with ethanol and separated from [γ-32 P]ATP by Sephadex G-25 column chromatography.
For the in vitro cap formation assay, the glutathione Sepharose CL-4B beads complexed with ∼0.1 µg protein of the fusion proteins were incubated in a buffer containing 10 mM Tris-HCl (pH 7.5), 3 mM MgCl 2 , 1 mM dithiothreitol, 0.1 mM EDTA, 20%(v/v) glycerol, 2.4 mM [α-32 P]GTP (400 Ci/mmol), and ∼50 pmol pppA-terminated RNA at 30_C for 60 min. After reaction, the RNA was digested with nuclease P1 and calf intestine alkaline phosphatase as described (16) . The resulting nucleotides were separated on DE81 paper by paper electrophoresis and visualized by Fuji BAS 2000.
Western blotting
The purified recombinant capping enzymes bound to the glutathione Sepharose CL-4B beads were suspended in a loading buffer for SDS-PAGE and heated at 90_C for 2 min. After the beads were removed by a brief centrifugation, the proteins were fractionated by SDS-PAGE, transferred to a polyvinilidene difluoride (PVDF) membrane electrophoretically (28) , and reacted with anti-GST antibody (Pharmacia) and then with horseradish-peroxidase conjugated protein A (Amersham) as described in the manual provided by the supplier. The protein hybridized with anti-GST-antibody was detected by an ECL-protein detection kit (Amersham).
A B
Site-directed mutagenesis
The mutant human capping enzymes bearing alanine substitution for K294, R299, E345, K458 or K460 were generated by the oligonucleotide-mediated mutagenesis of the human capping enzyme cDNA with Mutan-Express Km ™ (Takara) (28) . The entire ORF of the human capping enzyme cDNA was cloned at the SalI site of pKF18k (Takara), and hybridized with an appropriate primer. The resulting mutant human capping enzyme cDNAs were tested for their ability to complement the S.cerevisiae CEG1 gene.
Reverse transcribed polymerase chain reaction (RT-PCR)
RT-PCR was carried out to quantify the human capping enzyme mRNA. Total RNA was prepared from HeLa cells by the guanidium-isothiocyanate method and applied to an oligo(dT) cellulose column (28) . Single-stranded complementary DNA was made from poly(A) + RNA using AMV reverse transcriptase and oligo(dT) primer followed by the indicated cycles of the incubation at 94_C for 1 min, at 55_C for 1 min, and at 72_C for 2 min. The primers used for PCR were: 5′-GTGATTTTAATGTTC-GTCTGCAGTGTATAG-3′ for primer a; 5′-GCCAAAGAAGT-GAGCCATGAAATGGATGGA-3′ for primer b; 5′-GACGAAA-ATCCACAGAATTCAGACTGGGAG-3′ for primer c; and 5′-CT-TTTGTCTGTTCTCTGTCTCATGAAGACC-3′ for primer d.
Generation of yeast strains
The ORFs of the S.cerevisiae CEG1 and CET1 genes, and the human capping enzyme cDNAs were cloned between HindIII and PstI site (between the ADH1 promoter and terminator) of pGBT9 that carried TRP1 (Clontech), and the resulting plasmids were transfected into the ceg1∆ (MATa ura3 leu2 his3 trp1 ceg1::LEU2 CEG1-URA3) (21) and cet1∆ (MATa ade2 ura3 leu2 his3 trp1 cet1::LEU2 CET1-URA3) null mutant strains, in which the endogenous CEG1 or CET1 was disrupted by LEU2, but where episomal copies of CEG1 or CET1 cloned in YEp24 were maintained, respectively. Thus, the resulting ceg1∆ and cet1∆ null mutant strains grew in the absence of 5-fluoroorotic acid (5-FOA) but not in the presence of 5-FOA. After selecting trp + transformants, the ability of the human capping enzyme cDNAs to complement CEG1 and CET1 was examined by culturing them on an agar plate containing 5-FOA. 
RESULTS
Cloning of the human capping enzyme cDNA
Enzymes such as capping enzyme and DNA ligase form a stable complex with nucleotide monosphosphate as a reaction intermediate, and the KXDG motif, where X stands for any amino acid, is known to be essential for the formation of the enzyme-nucleotide monophosphate complex (20, (31) (32) (33) . In an attempt to identify a human capping enzyme cDNA, we searched for a protein harboring the KXDG motif in human genomic and cDNA databases and found that a short cDNA fragment in the Incyte cDNA database could encode a protein starting with ADG. As this clone contained a DNA fragment of 0.5 kb and an ORF could extend in both 5′-and 3′-directions, it should be a partial cDNA clone. To clone a full length cDNA, a HeLa cDNA library was screened with the cDNA fragment that was amplified by PCR using the above sequence, and three different but highly related cDNA clones were isolated. We designated these cDNAs as HCE1 (human mRNA capping enzyme 1), HCE1A and HCE1B. Sequencing of theses cDNAs revealed that HCE1 contained the longest ORF, which can specify a 69 kDa protein. In both HCE1A and HCE1B, the region between positions 1270 and 1338 of the HCE1 ORF was missing, which eliminates 23 amino acids from the C-terminal half of the HCE1 product (Hce1p) (Fig. 1A) . In addition to the above internal deletion, HCE1B has a translation termination codon corresponding to position 1441 of the HCE1 ORF, which deletes 117 C-terminal amino acids from Hce1p (Fig. 1A) . Although nucleotide sequences of the 3′-untranslated regions of HCE1 and HCE1A are identical, that of HCE1B is completely different from the other two clones. Otherwise, all these three cDNAs possess identical nucleotide sequences, strongly suggesting that they are alternatively spliced products.
HCE1 is the most probable candidate for the human capping enzyme cDNA because (i) the predicted molecular weight of Hce1p coincides with that of the partially purified human capping enzyme (26), (ii) Hce1p is highly related to the probable C.elegans capping enzyme Cel1p (27) over the entire protein, (iii) the C-terminal part of Hce1p shares high degrees of sequence identity with yeast and viral GTases (19) (20) (21) (34) (35) (36) , and (iv) the KXDG motif characteristic of the enzyme-GMP complex formation is conserved in Hce1p (20, (31) (32) (33) (Fig. 1B) .
Next, we intended to establish the enzyme activities of Hce1p. Hce1p, Hce1ap, Hce1bp and the S.cerevisiae GTase (Ceg1p) were expressed in bacterial cells as a fusion with glutathione S-transferase (GST), and the proteins were purified by glutathione Sepharose beads. Western blotting with anti-GST antibody confirmed the similar levels of each protein, but only Ceg1p and Hce1p formed a stable enzyme-GMP complex when incubated with [α-32 P]GTP (Fig. 2) . This result indicates that Hce1p harbors GTase activity and that the short internal deletion occurring in HCE1A and HCE1B abolished the GTase activity of Hce1p.
The N-terminal portion of Hce1p is highly homologous to that of Cel1p. Because Cel1p is shown to possess TPase activity (27) , we also looked for the TPase activity of Hce1p. As expected, Hce1p, Hce1ap and Hce1bp all efficiently removed the 32 P-labelled γ-phosphate at the 5′-terminus of RNA, while GST and Ceg1p did not. To further confirm the TPase activity of these proteins, a cap formation assay was performed using an RNA substrate with 5′-triphosphate ends. This assay should allow us to exclude the possibility of general phosphatase activity of these proteins, because guanylylation at the 5′-end of RNA requires diphosphateends of RNA. As shown in Figure 2 , Hce1p formed a cap structure at the 5′-triphosphate ends of an RNA substrate, demonstrating that HCE1 indeed encodes a human capping enzyme. Failure of Hce1ap and Hce1bp to cap the 5′-triphosphate ends of RNA is due to their lack of GTase activity. Taken together, we concluded that HCE1 is a cDNA for human capping enzyme.
Complementation of yeast CEG1 by HCE1
Comparison of the amino acid sequences of Hce1p, C.elegans Cel1p, and the yeast GTases revealed nine domains that are quite conserved among the yeast and higher eukaryotic GTases (Fig. 1B) . For convenience, these nine domains are referred to as domains I-IX according to their order from the N-terminus. Domain II contains the KXDG motif in which lysine at 294 is thought to form a phosphoamide bond with GMP (32). According to the structure of PBCV-1 GTase, arginine at 299 in domain II and glutamic acid at 345 in domain III may form hydrogen bonds with hydroxyl groups of ribose of GTP. Further, lysine at 458 and at 460 in domain VI may also interact with the α-phosphate of GTP in the closed form and in the open form, respectively (24) .
Because all these important amino acids are conserved in Hce1p, we asked whether human HCE1 functionally substitutes for the yeast CEG1 gene. The S.cerevisiae ceg1∆ null mutant strain in which the endogenous CEG1 gene was disrupted, but where episomal copies of CEG1 were maintained in an URA3-containing plasmid (YEp24), grew in the absence of 5-FOA, but died in the presence of 5-FOA from the lack of a functional CEG1 gene (Fig. 3A) (21) . Expression of HCE1 under the control of ADH1 promoter supported the growth of the ceg1∆ null mutant strain, even in the presence of 5-FOA, demonstrating that human capping enzyme functionally complements yeast GTase. HCE1A and HCE1B failed to rescue the ceg1∆ null mutants in the same experiment. Furthermore, none of the mutant HCE1 genes encoding the protein with alanine substitution for K294, R299, E345, K458 or K460 complemented CEG1 (Fig. 3B) , confirming that all these conserved amino acids are essential for the GTase activity. These results are consistent with the previous findings that the proteins specified by HCE1A and HCE1B are defective in GTase activity and with the results of the mutation study with CEG1 by Wang et al. (37) .
Levels of the human capping enzyme mRNAs
As there are three mRNA species of human capping enzyme, we examined the levels of these mRNAs. Northern blotting of the human capping enzyme mRNA did not allow us to distinguish among the HCE1, HCE1A and HCE1B mRNAs. Therefore, we used RT-PCR with different sets of primers specific and not-specific to HCE1 (Fig. 4) . The combination of primers specific to HCE1 (primers b and c) gave rise to only one band which fits the size estimated from the cDNA sequence (124 bp). The amount of PCR product increased in a PCR-cycle dependent manner; a weak band appeared after 25 cycles, and it became significantly thicker after 30 cycles. Thus, this system can be applied to estimate the relative abundance of the three mRNAs for human capping enzyme.
Primers for common sequences among the three cDNAs (primers a and c) produced two bands of 288 and 219 bp. From the cDNA sequences, the thick 288 bp band was amplified from HCE1, and the faint 219 bp band was formed from HCE1A and HCE1B. Use of the primers that hybridized with HCE1 and HCE1A (primers a and d) also led to the amplification of two bands, the thick 478 bp band generated from HCE1 and the faint 409 bp band produced from HCE1A. In both cases, the amounts of the DNA fragment amplified from HCE1 were significantly higher than those from HCE1A and HCE1B. All these results indicate that mRNA for HCE1 is predominantly expressed among the three human capping enzyme mRNA species.
Complementation of yeast CET1 by HCE1
CET1 was recently identified as the S.cerevisiae TPase (β subunit of capping enzyme) gene (22) . Cet1p, however, shares no apparent sequence homology with Hce1p and Cel1p, and has no known phosphatase motif. As mentioned before, both Hce1p and Cel1p contain a motif in the N-terminal TPase domains of amino acid sequence characteristic of the active site of tyrosine phosphatases, and the active site cysteine of the protein tyrosine phosphatases is also conserved in these domains (39) . This prompted us to examine the ability of HCE1 to functionally complement CET1. The cells of cet1∆ bearing the episomal copies of CET1 or HCE1 survived in the presence of 5-FOA, but those with HCE1A or HCE1B died in the same culture condition. All the cells grew well when 5-FOA was absent (Fig. 5) . These results indicate that at least in the level induced by ADH1 promoter, the TPase domain of the human capping enzyme cannot functionally substitute for the yeast TPase in vivo.
DISCUSSION
We have identified HCE1, a human cDNA for the mRNA-capping enzyme. Bacterially expressed Hce1p possessed both TPase and GTase activities, and it formed a cap structure at the 5′-triphosphate ends of RNA. This is the first study that demonstrates both TPase and GTase activities with a single type of cDNA. Human capping enzyme mRNA seems to be spliced differently to produce two additional mRNA species, which are represented by HCE1A and HCE1B. From the nucleotide sequences, the HCE1A and HCE1B products appear to have the same internal 23 amino acid deletion within the C-terminal part of Hce1p, and an additional 117 amino acids within the C-terminal of Hce1p are also missing in the HCE1B product. Both Hce1ap and Hce1bp displayed TPase activity, while neither of them had GTase activity. Thus demonstrating that, as in the C.elegans Cel1p, the N-terminal part of Hce1p is responsible for TPase activity, and the C-terminal part is required for the GTase activity (27) . In addition, 23 amino acids between positions 1269 and 1338 were essential for GTase activity of Hce1p. This is also consistent with the results that HCE1, but not HCE1A and HCE1B, functionally complemented S.cerevisiae CEG1.
During preparation of this paper, Yue et al. and McCracken et al. reported the cDNAs for the human and mouse capping enzyme (37, 40) . The amino acid sequence of the reported human capping enzyme differs by only one amino acid from that of Hce1p. It is also demonstrated in the paper (37, 40) that the C-terminal GTase domain is responsible for the binding to the phosphorylated C-terminal domain of the largest subunit of RNA polymerase II, which explains the specific capping of class II transcripts.
Cel1p is shown to have TPase activity (27) , but whether GTase activity resides in Cel1p remains to be demonstrated. When the sequences of Cel1p and Hce1p are compared, 14 amino acids in the C-terminal of Hce1p are missing in Cel1p. Although the importance of the 14 C-terminal amino acids of Hce1p for GTase activity is not known, the absence of these amino acids in Cel1p may account for its lack of GTase activity. Furthermore, the C.elegans capping enzyme mRNA may also be alternatively spliced so as to produce the GTase-deficient but TPase positive enzymes.
CET1 turned out to be the gene for the S.cerevisiae TPase (22) . In this paper, we found that among three human capping enzyme cDNAs only HCE1 functionally complemented CET1 in vivo, while all the cDNA products were active as TPase in vitro. This was a rather unexpected result because Takagi et al. (27) demonstrated the whole capping enzyme activity in vitro by combining Ceg1p and Cel1p that is also defective in GTase activity. Because the amino acid sequence of Cet1p is diverged from those of the higher eukaryotic enzymes, the catalytic mechanism of TPase may be different in yeast and higher eukaryotes, which may account for the failure of HCE1A and HCE1B to functionally complement CET1 in vivo. Another possibility may be that both α-and β-subunits should be associated with each other to be able to function as a capping enzyme in vivo, and that the human TPase domain has a low affinity for the yeast GTase.
The physiological roles of a GTase-deficient capping enzyme are unclear. From the experiments by RT-PCR, it appears that the level of mRNA for HCE1 was significantly higher than those for HCE1A and HCE1B. This result implies that the enzyme possessing both TPase and GTase activities is predominantly expressed, and that the GTase-deficient enzymes specified by HCE1A and HCE1B are only minor populations. On the other hand, the molecular mass of the purified yeast capping enzyme is ∼180 kDa (18) . As the calculated molecular mass of α-and β-subunits of yeast enzyme are 52 and 62 kDa, respectively (19, 22) , the subunit structure of the yeast capping enzyme can be α1β2. Accordingly, human GTase-deficient enzymes may be associated with the native enzyme.
